Literature DB >> 15534106

Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma.

Tong Tong1, Yali Zhong, Jianping Kong, Lijia Dong, Yongmei Song, Ming Fu, Zhihua Liu, Mingrong Wang, Liping Guo, Shixin Lu, Ming Wu, Qimin Zhan.   

Abstract

PURPOSE: Aurora-A/STK15/BTAK, a centrosome-associated oncogenic protein, is implicated in the control of mitosis. Overexpression of Aurora-A has been shown to result in chromosomal aberration and genomic instability. Multiple lines of evidence indicate that Aurora-A induces cell malignant transformation. In the current study, we are interested in investigating the expression of Aurora-A in human esophageal squamous cell carcinoma (ESCC) and characterizing the association of Aurora-A with ESCCmalignant progression. EXPERIMENTAL
DESIGN: Aurora-A protein expression was examined in 84 ESCC tissues and 81 paired normal adjacent tissues by either immunohistochemistry or Western blot analysis. In addition, a gene-knockdown small interfering RNA technique was used in ESCC cells to investigate whether Aurora-A contributes to the ability of a tumor to grow invasively.
RESULTS: The amount of Aurora-A protein in ESCC was considerably higher than that in normal adjacent tissues. Overexpression of Aurora-A was observed in 57 of 84 (67.5%) ESCC samples. In contrast, <2% of normal adjacent tissue displayed high expression of Aurora-A. Interestingly, overexpression of Aurora-A seemed to correlate with the invasive malignancy of ESCC. Disruption of endogenous Aurora-A using small interfering RNA technique substantially suppressed cell migrating ability.
CONCLUSION: The findings presented in this report show that Aurora-A expression is elevated in human esophageal squamous cell carcinoma and is possibly associated with tumor invasion, indicating that overexpression of Aurora-A may contribute to ESCC occurrence and progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534106     DOI: 10.1158/1078-0432.CCR-04-0806

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  62 in total

1.  Differences of onset age and survival rates in esophageal squamous cell carcinoma cases with and without family history of upper gastrointestinal cancer from a high-incidence area in North China.

Authors:  Denggui Wen; Shijie Wang; Liwei Zhang; Jianhui Zhang; Lizhen Wei; Xiuqing Zhao
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

2.  Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780.

Authors:  Jayasree S Nair; Alan L Ho; Archie N Tse; Jesse Coward; Haider Cheema; Grazia Ambrosini; Nicholas Keen; Gary K Schwartz
Journal:  Mol Biol Cell       Date:  2009-02-18       Impact factor: 4.138

3.  Expression of migfilin is increased in esophageal cancer and represses the Akt-β-catenin activation.

Authors:  Huan He; Fang Ding; Sheng Li; Hongyan Chen; Zhihua Liu
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

4.  Inhibition of Aurora A promotes chemosensitivity via inducing cell cycle arrest and apoptosis in cervical cancer cells.

Authors:  Jian-Ming Sun; Li-Na Yang; Han Xu; Bin Chang; Hua-Ying Wang; Gong Yang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

5.  Differential expression of aurora-A kinase in T-cell lymphomas.

Authors:  Rashmi Kanagal-Shamanna; Norman L Lehman; James P O'Donnell; Megan S Lim; Daniel S Schultz; Dhananjay A Chitale; Carlos E Bueso-Ramos; L Jeffrey Medeiros; Kedar V Inamdar
Journal:  Mod Pathol       Date:  2013-02-15       Impact factor: 7.842

6.  Pdx-1-driven overexpression of aurora a kinase induces mild ductal dysplasia of pancreatic ducts near islets in transgenic mice.

Authors:  Steven L Warner; Ruben M Muñoz; David J Bearss; Paul Grippo; Haiyong Han; Daniel D Von Hoff
Journal:  Pancreas       Date:  2008-10       Impact factor: 3.327

7.  Essential roles of mTOR/Akt pathway in Aurora-A cell transformation.

Authors:  Makoto Taga; Eiji Hirooka; Toru Ouchi
Journal:  Int J Biol Sci       Date:  2009-06-19       Impact factor: 6.580

8.  Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers.

Authors:  E Burum-Auensen; P M DeAngelis; A R Schjølberg; J Røislien; O Mjåland; O P F Clausen
Journal:  Cell Prolif       Date:  2008-08       Impact factor: 6.831

Review 9.  Physiological and oncogenic Aurora-A pathway.

Authors:  Toshiaki Saeki; Mutsuko Ouchi; Toru Ouchi
Journal:  Int J Biol Sci       Date:  2009-11-26       Impact factor: 6.580

10.  BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers.

Authors:  Y-K Lee; E Choi; M A Kim; P-G Park; N-H Park; H Lee
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.